Priority Date: 05.10.07 (EP 20070291214)

Use of Recombinant LAG-3 or the Derivatives Thereof for Eliciting Monocyte Immune Response

  • Application ID: EP12196313
  • Status: The patent has been granted

Applicant

Technology company logo small
Technology Company

Attorney

operating since 1907
Headquarter in London and 2 offices
active in Legal Services, IP Consulting, and IP Portfolio Processing

Specialization

This EP application has the IPC class A61 (MEDICAL OR VETERINARY SCIENCE; HYGIENE). Reddie & Grose LLP is specialised in A61 (MEDICAL OR VETERINARY SCIENCE; HYGIENE). Here you find a list of all patent agent firms which are specialized in this IPC class. For a similar patent, they might be a good choice.

Timeline

  • 05.10.2007 - Priority Date (EP 20070291214)
  • 19.06.2013 - Publication A1 (EP2604275)
  • 22.11.2017 - Publication B1 (EP2604275)